Clinical profile and outcomes of multisystem inflammatory syndrome in children (MIS-C): Hospital-based prospective observational study from a tertiary care hospital in South India
- PMID: 35869845
- DOI: 10.1111/jpc.16129
Clinical profile and outcomes of multisystem inflammatory syndrome in children (MIS-C): Hospital-based prospective observational study from a tertiary care hospital in South India
Abstract
Aim: To study the clinical profile and outcomes in children with multisystem inflammatory syndrome in children (MIS-C).
Methods: Children aged 1 month to 15 years presenting with MIS-C (May 2020 to November 2021) were enrolled. Clinical, laboratory, echocardiography parameters and outcomes were analysed.
Results: Eighty-one children (median age 60 months (24-100)) were enrolled. Median duration of fever was 5 days (3-7). Twenty-nine (35.8%) had shock (severe MIS-C) including 23 (28.3%) requiring inotropes (median duration = 25 h (7.5-33)). Ten required mechanical ventilation, 12 had acute kidney injury and 1 child died. Left ventricular (LV) dysfunction was seen in 38 (46.9%), 16 (19.7%) had coronary artery abnormalities (CAA) and 13 (20%) had macrophage activation syndrome. Sixty-one (75.3%) were SARS CoV-2 positive (10 by RT-PCR and 51 by serology). Sixty-eight (83.9%) received immunomodulators. Younger age was significantly associated with CAA (P value = 0.05). Older age, LV dysfunction, SARS CoV-2 positivity, low platelet count and elevated serum ferritin were significantly associated with severe MIS-C (univariate analysis). Younger age was an independent predictor of CAA (P = 0.05); older age (P = 0.043) and low platelet count (P = 0.032) were independent predictors of severe MIS-C (multivariate logistic regression analysis).
Conclusion: Our patients had diverse clinical manifestations with a good outcome. Younger age was significantly associated with CAA. Older age, LV dysfunction, low platelet count and elevated serum ferritin were significantly associated with severe MIS-C. Younger age is an independent predictor of CAA. Older age and low platelet count are independent predictors of severe MIS-C.
Keywords: Kawasaki disease; MIS-C; SARS CoV-2; coronary artery abnormalities; left ventricular systolic dysfunction; macrophage activation syndrome.
© 2022 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).
Similar articles
-
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.Crit Care. 2020 Nov 26;24(1):666. doi: 10.1186/s13054-020-03332-4. Crit Care. 2020. PMID: 33243303 Free PMC article.
-
Clinical manifestations and outcomes associated with PICU admission in children with multisystem inflammatory syndrome in Taiwan: A retrospective cohort study.Int J Rheum Dis. 2024 Jan;27(1):e14970. doi: 10.1111/1756-185X.14970. Epub 2023 Nov 10. Int J Rheum Dis. 2024. PMID: 37947261
-
Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.J Trop Pediatr. 2021 Jul 2;67(3):fmab055. doi: 10.1093/tropej/fmab055. J Trop Pediatr. 2021. PMID: 34170328 Free PMC article.
-
Multisystem Inflammatory Syndrome in Children (MIS-C).Curr Allergy Asthma Rep. 2022 May;22(5):53-60. doi: 10.1007/s11882-022-01031-4. Epub 2022 Mar 22. Curr Allergy Asthma Rep. 2022. PMID: 35314921 Free PMC article. Review.
-
Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.World J Pediatr. 2021 Aug;17(4):335-340. doi: 10.1007/s12519-021-00435-y. Epub 2021 May 20. World J Pediatr. 2021. PMID: 34013488 Free PMC article. Review.
Cited by
-
Evaluation of clinical and laboratory findings in MIS-C patients associated with COVID-19: An experience from the Northwest of Iran.PLoS One. 2024 Nov 21;19(11):e0313843. doi: 10.1371/journal.pone.0313843. eCollection 2024. PLoS One. 2024. PMID: 39570835 Free PMC article.
-
In-hospital unfavorable outcomes of MIS-C during 2020-2022: a systematic review.Eur J Pediatr. 2024 Dec;183(12):5071-5084. doi: 10.1007/s00431-024-05787-x. Epub 2024 Oct 1. Eur J Pediatr. 2024. PMID: 39349752
-
Platelet role in the prediction of MIS-C severity.Front Pediatr. 2023 Jun 8;11:1153623. doi: 10.3389/fped.2023.1153623. eCollection 2023. Front Pediatr. 2023. PMID: 37360365 Free PMC article.
-
Impact of time to diagnosis on the occurrence of cardiogenic shock in MIS-C post-COVID-19 infection.World J Pediatr. 2023 Jun;19(6):595-604. doi: 10.1007/s12519-022-00681-8. Epub 2023 Jan 6. World J Pediatr. 2023. PMID: 36607546 Free PMC article.
References
-
- Feldstein LR, Rose EB, Horwitz SM et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 2020; 383: 334-46.
-
- Jiang L, Tang K, Levin M et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect. Dis. 2020; 20: e276-88.
-
- Shah SK, Munoz AC. Multisystem inflammatory syndrome in children in COVID-19 pandemic. Indian J. Pediatr. 2020; 87: 671-3.
-
- Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: A systematic review. Eur. J. Pediatr. 2021; 180: 2019-34.
-
- World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. 2020. Available at: https://www.who.int/news-room/commentaries/detail/multisystem-inflammato.... Accessed on 09 January 2022.
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous